# Role of NADPH Oxidase in Microvascular Dysfunction Following GDM

> **NCT05946798** · EARLY_PHASE1 · RECRUITING · sponsor: **Anna Stanhewicz, PhD** · enrollment: 40 (estimated)

## Conditions studied

- Gestational Diabetes
- Oxidative Stress
- Vascular Endothelial Function

## Interventions

- **DRUG:** Acetylcholine
- **DRUG:** Insulin aspart

## Key facts

- **NCT ID:** NCT05946798
- **Lead sponsor:** Anna Stanhewicz, PhD
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-30
- **Primary completion:** 2027-06-30
- **Final completion:** 2028-06-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05946798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05946798, "Role of NADPH Oxidase in Microvascular Dysfunction Following GDM". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05946798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*